申请人:SANDOZ LTD.
公开号:EP0564397A1
公开(公告)日:1993-10-06
The invention relates to substituted phenylquinazoline derivatives. It concerns the compounds of formula I
wherein the substituents have various significances.
They may be obtained by a process comprising dehydration, ring closure and/or alkylation, and optional recovery in racemic or optically active, in free base or acid addition salt form.
They possess pharmacological activity, in particular,they raise the blood serum high density lipoprotein level and are thus indicated for use in the treatment of atherosclerosis.
本发明涉及取代苯基喹唑啉衍生物。它涉及式I的化合物,其中取代基具有不同的意义。它们可以通过脱水、环闭和/或烷基化的过程获得,并可以在外消旋或光学活性、自由碱或酸盐形式中进行回收。它们具有药理活性,特别是能提高血清高密度脂蛋白水平,因此适用于动脉硬化的治疗。